Shubh G.

Shubh G. is a seasoned executive with extensive experience in the biotechnology and pharmaceutical industries, currently serving as the VP, US Franchise Head for Immuno-Oncology and GI Tumors at AstraZeneca since March 2022. Shubh has a proven track record in commercialization, operations, and strategic marketing, having previously held the position of Chief Commercial Officer at Fennec Pharmaceuticals Inc. and Vice President of Commercial Strategy & Operations at Odonate Therapeutics™. Additional roles include leadership positions at Celgene, AVEO Oncology, Bayer, ARIAD Pharmaceuticals, Takeda Oncology, and Pfizer, where Shubh contributed to major product launches and global marketing initiatives. Shubh holds a BSc Hons in Biochemistry from the University of Bath and has recently completed an Executive Education program at Kellogg.